1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Stress testing the Centiloid : Precision and variability of PET quantification of amyloid pathology
(
- Contribution to journal › Article
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
(
- Contribution to journal › Article
-
Mark
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium
(
- Contribution to journal › Article
-
Mark
Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
(
- Contribution to journal › Article
-
Mark
Amyloid-PET imaging predicts functional decline in clinically normal individuals
(
- Contribution to journal › Article
- 2023
-
Mark
Longitudinal amyloid and tau PET imaging in Alzheimer's disease : A systematic review of methodologies and factors affecting quantification
(
- Contribution to journal › Scientific review
-
Mark
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
(
- Contribution to journal › Article
-
Mark
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
(
- Contribution to journal › Article